Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Announcement under Regulation 30 (LODR)-Change in Directorate

· Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE ·

The Board of Directors of the Company at their meeting held on 31-03-2025 (1) rescinded its decision to appoint Mr. Manoj Lodha as Executive Director & Chief Financial Officer upon his withdrawal of consent and (2) Mr. Sachin Mehta to continue as Joint Managing Director & Chief Financial Officer of the Company. (Details given in the files attached).

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

Later from Sudarshan Pharma Industries

All Sudarshan Pharma Industries news releases